- Fulcrum ends sickle cell ambitions following regulatory feedback, will seek exitFulcrum Therapeutics is scrapping its sole clinical-stage medicine after feedback from the FDA that referenced a recently pulled cancer drug from Ipsen. Fulcrum had planned to enter a registratio…Endpoints · 1mo ago↗ source
- Cancer cases weigh down Abivax’s Phase 3 maintenance data in ulcerative colitisAbivax has proclaimed that its maintenance trial in ulcerative colitis delivered “landmark” results, and the drug's safety profile has previously been one of its main potential selling points. But…Endpoints · 1mo ago↗ source
- Praxis sinks on late-stage study fail for seizure pill, halts second trialPraxis Precision Medicines has had a decent run over the past eight months or so, with two major clinical wins. But on Monday, the company disclosed a late-stage failure for its investigational s…